bioRxivBioengineering
Synthetic single domain antibodies for the conformational trapping of membrane proteins
I. Zimmermann, P. Egloff, C. Hutter, P. Stohler, N. Bocquet, M. Hug, M. Siegrist, L. Svacha, J. Gera, S. Gmuer, P. Spies, D. Gygax, E. R. Geertsma, R. J. P. Dawson, M. A. Seeger
Abstract
Single domain antibodies called nanobodies are excellent affinity reagents for membrane proteins. However, their generation relies on immunizations, which is only amenable to robust proteins and impedes selections in the presence of non-covalent or toxic ligands. To overcome these key limitations, we developed a novel in vitro selection platform, which builds on synthetic nanobodies called sybodies. Inspired by the shape diversity of natural nanobodies, three sybody libraries exhibiting different randomized surface shapes were engineered for high thermal stability. Using ribosome display, exceptionally large libraries were pre-enriched against membrane protein targets and subsequently funneled into a robust phage display process, thereby reducing selection bias. We successfully generated conformation-selective, high affinity sybodies against the human glycine transporter GlyT1, the human equilibrative nucleotide transporter ENT1 and a bacterial ABC transporter. Our platform builds exclusively on commercially available reagents and enables non-specialized labs to generate conformation-specific binders against previously intractable protein targets.
- organism: human
- organism: bacteria (other)
- assay: proteomics
- research focus: protein folding & dynamics
- approach: deep learning
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selection of nanobodies against liponanoparticle-embedded membrane proteins by yeast surface display
Greg J. Dodge, Hayley L. Knox, … Karen N. Allen·Protein SciencePeer-reviewed·Sep 13, 2025
- Platform for rapid nanobody discovery in vitro
C. McMahon, A. S. Baier, … A. C. Kruse·bioRxiv·Jun 16, 2017
- Generation of a Synthetic Single Domain Antibody Library for Radiopharmaceutical Ligand Discovery
Lucinda A. Hall, Rachael E. Guenter, … Benjamin M. Larimer·bioRxiv·May 14, 2025
- Phage-displayed synthetic library and screening platform for nanobody discovery
Baolong Xia, Ah‐Ram Kim, … Norbert Perrimon·bioRxiv·Dec 20, 2024
- Single Domain Antibody Inhibitors Target the Coiled Coil Arms of the Bacillus subtilis SMC complex
Ophélie Gosselin, Michael Taschner, … Stephan Gruber·eLifePeer-reviewed·May 11, 2026
- Unique Binding and Stabilization Mechanisms Employed By and Engineered Into Nanobodies.
N. E. Ketaren, P. C. Fridy, … M. P. Rout·bioRxiv·Oct 22, 2023